A detailed history of Interchange Capital Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 1,942 shares of NVO stock, worth $165,070. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,942
Previous 1,967 1.27%
Holding current value
$165,070
Previous $280,000 17.5%
% of portfolio
0.08%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.07 - $145.42 $2,976 - $3,635
-25 Reduced 1.27%
1,942 $231,000
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $241,370 - $288,971
1,967 New
1,967 $280,000
Q1 2021

May 05, 2021

SELL
$67.06 - $75.82 $26,689 - $30,176
-398 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $25,428 - $29,372
398 New
398 $27,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.